CBT-006 is a molecule that can sequester cholesterol. CBT-006 is a unique topical formulation following 505b(2) regulatory pathway. CBT-006 applied topically in repeat dosing as eye drops will dissolve cholesterol and other lipids deposited at the orifice of meibomian glands to improve meibum quality and meibomian gland health.
Clinical data shows that CBT-006 can quickly and significantly improve symptoms, and has long-lasting effects after stopping the drug, and its safety is excellent. CBT-006 also demonstrates statistical significance in improving dry eye symptoms.